G-CSF-primed haplo-identical HSCT with intensive immunosuppressive and myelosuppressive treatments does not increase the risk of pre-engraftment bloodstream infection: a multicenter case

G-CSF-primed haplo-identical HSCT with intensive immunosuppressive and myelosuppressive treatments does not increase the risk of pre-engraftment bloodstream infection: a multicenter case–control study

Published:2019-01-26 Issue:5 Volume:38 Page:865-876
ISSN:0934-9723
Container-title:European Journal of Clinical Microbiology & Infectious Diseases
language:en
Short-container-title:Eur J Clin Microbiol Infect Dis

Author:

Ren Jinhua,Lin Qiaoxian,Chen Weimin,Lin Congmeng,Zhang Yuxin,Chen Cunrong,Chen Shaozhen,Yuan Xiaohong,Chen Ping,Luo Xiaofeng,Lin Yun,Shen Lvying,Guo Mengxian,Chen Qiuru,Xiao Min,Chen Yongquan,Wu Xueqiong,Zeng Yanling,Chen Zhizhe,Ma Xudong,Hu Jianda,Yang Ting

Funder

National and Fujian Provincial Key Clinical Specialty Discipline Construction Program, China, National High Technology Research and Development Program of China, 863 program

National Public Health Grand Research Foundation

National Natural Science Foundation of China

Fujian Provincial Key Laboratory Foundation of Hematology

Natural Science Foundation of Fujian Province

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

http://link.springer.com/article/10.1007/s10096-019-03482-6/fulltext.html

Reference46 articles.

1. Poutsiaka DD, Munson D, Price LL, Chan GW, Snydman DR (2011) Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated. Bone Marrow Transplant 46:300–307